XML 51 R40.htm IDEA: XBRL DOCUMENT v3.19.2
Long-Term Investments (Details)
6 Months Ended
Jun. 30, 2019
Dec. 31, 2018
Aug. 31, 2017
Ownership percentage     73.00%
Braingenesis Biotechnology Co., Ltd., a Taiwan company [Member]      
Ownership percentage 0.17% 0.17%  
Accounting treatment Cost Method    
Genepharm Biotech Corporation, a Taiwan company [Member]      
Ownership percentage 0.72% 0.72%  
Accounting treatment Cost Method    
BioHopeKing Corporation, a Taiwan company [Member]      
Ownership percentage 7.13% 7.13%  
Accounting treatment Cost Method    
BioFirst Corporation, a Taiwan company [Member]      
Ownership percentage 15.88% 15.88%  
Accounting treatment Equity Method    
Rgene Corporation, a Taiwan company [Member]      
Ownership percentage 31.62% 31.62%  
Accounting treatment Equity Method